Amgen Buy or Sell Recommendation

Macroaxis provides Amgen Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amgen positions. The advice algorithm takes into account all of Amgen Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Amgen buy-and-hold prospective. Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
Amgen Inc -- USA Stock  

USD 169.38  0.62  0.36%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Amgen Inc is 'Strong Sell'.
For the selected time horizon Amgen Inc has a mean deviation of 0.6275, semi deviation of 0.0, standard deviation of 0.8153, variance of 0.6647, downside variance of 0.0 and semi variance of 0.0
Macroaxis provides buy, hold, or sell suggestion on Amgen Inc to complement and cross-verify current analyst consensus on Amgen Inc. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Amgen is not overpriced, please confirm all Amgen Inc fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen Inc has Price to Earning of 15.43 times, we suggest you validate Amgen Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.36Value At Risk1.59
Potential Upside0.82Standard Deviation0.82
 Return Density 

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares59 M11 B
Vanguard Group IncCommon Shares52.5 M9.8 B
Capital Research Global InvestorsCommon Shares52.5 M9.8 B
Blackrock IncCommon Shares49.8 M9.3 B
State Street CorpCommon Shares31.9 M6 B
Primecap Management CoCommon Shares22.3 M4.2 B
Northern Trust CorpCommon Shares9.7 M1.8 B

Amgen Greeks

Alpha over DOW
βBeta against DOW=0.82
Overall volatility
 IrInformation ratio =0.51

Amgen Volatility Alert

Amgen Inc exhibits very low volatility with skewness of 0.32 and kurtosis of 0.2. However, we advise investors to further study Amgen Inc technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Amgen to competition
FundamentalsAmgenPeer Average
Return On Equity26.43 % (15.17) %
Return On Asset8.27 % (15.64) %
Profit Margin35.46 % (5.5) %
Operating Margin44.49 % (10.91) %
Current Valuation121.59 B152.14 B
Shares Outstanding725.91 M1.43 B
Shares Owned by Insiders0.15 % 6.91 %
Shares Owned by Institutions80.27 % 18.37 %
Number of Shares Shorted7.81 M3.24 M
Price to Earning15.43 times40.69 times
Price to Book3.9 times14.44 times
Price to Sales5.33 times17.81 times
Revenue23.05 B9.85 B
Gross Profit18.83 B21.75 B
EBITDA12.36 B1.41 B
Net Income8.17 B517.71 M
Cash and Equivalents39.23 B3.89 B
Cash per Share53.76 times5.17 times
Total Debt35.06 B7.36 B
Debt to Equity110.5 % 0.72 %
Current Ratio6.2 times3.3 times
Book Value Per Share43.41 times13.64 times
Cash Flow from Operations10.47 B1.25 B
Short Ratio2.81 times2.09 times
Earnings Per Share10.98 times2.3 times
Price to Earnings To Growth3.22 times1.22 times
Number of Employees17.9 K10.67 K
Market Capitalization122.95 B29.78 B
Total Asset71.58 B126.86 B
Retained Earnings(438 M)38.24 B
Working Capital29.85 B3.58 B
Current Asset38.52 B36.8 B
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Acquisition by Sharer Kevin W of 318500 shares of Amgen subject to Rule 16b-3 [view details]
Risk Adjusted Performance(0.16)
Market Risk Adjusted Performance0.4596
Mean Deviation0.6275
Coefficient Of Variation(227.19)
Standard Deviation0.8153
Information Ratio(0.51)
Jensen Alpha(0.33)
Total Risk Alpha(0.48)
Treynor Ratio0.4496
Maximum Drawdown2.52
Value At Risk(1.59)
Potential Upside0.8206

Current Valuation

Amgen Current Valuation Analysis
Amgen Inc is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is presently estimated at about 399.06 Billion. Amgen totals roughly 121.59 Billion in current valuation claiming about 30% of equities listed under Pharmaceuticals And Biosciences industry.